324 related articles for article (PubMed ID: 33578119)
21. Possible Roles of IL-33 in the Innate-Adaptive Immune Crosstalk of Psoriasis Pathogenesis.
Cannavò SP; Bertino L; Di Salvo E; Papaianni V; Ventura-Spagnolo E; Gangemi S
Mediators Inflamm; 2019; 2019():7158014. PubMed ID: 31736655
[TBL] [Abstract][Full Text] [Related]
22. The roles of cells and cytokines in the pathogenesis of psoriasis.
Coimbra S; Figueiredo A; Castro E; Rocha-Pereira P; Santos-Silva A
Int J Dermatol; 2012 Apr; 51(4):389-95; quiz 395-8. PubMed ID: 22435425
[TBL] [Abstract][Full Text] [Related]
23. Genome-wide association scan yields new insights into the immunopathogenesis of psoriasis.
Elder JT
Genes Immun; 2009 Apr; 10(3):201-9. PubMed ID: 19262574
[TBL] [Abstract][Full Text] [Related]
24. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells.
Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM
Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823
[TBL] [Abstract][Full Text] [Related]
25. Preliminary study of histamine H
Han SH; Hur MS; Kim MJ; Kim BM; Kim KW; Kim HR; Choe YB; Ahn KJ; Lee YW
J Dermatol Sci; 2017 Oct; 88(1):29-35. PubMed ID: 28592369
[TBL] [Abstract][Full Text] [Related]
26. [IL-23 and Th17 cells in infections and psoriasis].
Kagami S
Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(1):13-9. PubMed ID: 21372509
[TBL] [Abstract][Full Text] [Related]
27. Mass cytometry analysis of blood immune cells from psoriasis patients on biological therapy.
Solberg SM; Aarebrot AK; Sarkar I; Petrovic A; Sandvik LF; Bergum B; Jonsson R; Bryceson YT; Appel S
Eur J Immunol; 2021 Mar; 51(3):694-702. PubMed ID: 33226128
[TBL] [Abstract][Full Text] [Related]
28. The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis.
Egeberg A; Gisondi P; Carrascosa JM; Warren RB; Mrowietz U
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1695-1706. PubMed ID: 32022950
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-23 in the pathogenesis and treatment of psoriasis.
Kollipara R; Downing C; Gordon R; Tyring S
Skin Therapy Lett; 2015; 20(2):1-4. PubMed ID: 25807335
[TBL] [Abstract][Full Text] [Related]
30. Signaling pathways and targeted therapies for psoriasis.
Guo J; Zhang H; Lin W; Lu L; Su J; Chen X
Signal Transduct Target Ther; 2023 Nov; 8(1):437. PubMed ID: 38008779
[TBL] [Abstract][Full Text] [Related]
31. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
32. Signs of innate immune activation and premature immunosenescence in psoriasis patients.
Šahmatova L; Sügis E; Šunina M; Hermann H; Prans E; Pihlap M; Abram K; Rebane A; Peterson H; Peterson P; Kingo K; Kisand K
Sci Rep; 2017 Aug; 7(1):7553. PubMed ID: 28790368
[TBL] [Abstract][Full Text] [Related]
33. Genetics of psoriasis.
Mahil SK; Capon F; Barker JN
Dermatol Clin; 2015 Jan; 33(1):1-11. PubMed ID: 25412779
[TBL] [Abstract][Full Text] [Related]
34. Immune responses and therapeutic options in psoriasis.
Afonina IS; Van Nuffel E; Beyaert R
Cell Mol Life Sci; 2021 Mar; 78(6):2709-2727. PubMed ID: 33386888
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of RUNX3 moderates the frequency of Th17 and Th22 cells in patients with psoriasis.
Fu D; Song X; Hu H; Sun M; Li Z; Tian Z
Mol Med Rep; 2016 Jun; 13(6):4606-12. PubMed ID: 27082311
[TBL] [Abstract][Full Text] [Related]
36. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
[TBL] [Abstract][Full Text] [Related]
37. IL-23/Th17 Axis: A Potential Therapeutic Target of Psoriasis.
Sharma A; Upadhyay DK; Gupta GD; Narang RK; Rai VK
Curr Drug Res Rev; 2022; 14(1):24-36. PubMed ID: 34238181
[TBL] [Abstract][Full Text] [Related]
38. The immunogenetics of Psoriasis: A comprehensive review.
Harden JL; Krueger JG; Bowcock AM
J Autoimmun; 2015 Nov; 64():66-73. PubMed ID: 26215033
[TBL] [Abstract][Full Text] [Related]
39. Targeting the Th17 pathway in psoriasis.
Elloso MM; Gomez-Angelats M; Fourie AM
J Leukoc Biol; 2012 Dec; 92(6):1187-97. PubMed ID: 22962689
[TBL] [Abstract][Full Text] [Related]
40. Neutrophil Extracellular Traps Induce Human Th17 Cells: Effect of Psoriasis-Associated TRAF3IP2 Genotype.
Lambert S; Hambro CA; Johnston A; Stuart PE; Tsoi LC; Nair RP; Elder JT
J Invest Dermatol; 2019 Jun; 139(6):1245-1253. PubMed ID: 30528823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
